Accelerating access to precision oncology trials: risk-benefit framework for local biomarker tests for patient enrollment

Elizabeth J. Shaughnessy, Abde M. Abukhdeir, Thomas R. Battersby, Bowen Cui, Simon P. Dearden, Lindee Goh, Janet Y. Jin, Alexander G. Kohlmann, Kelly S. Oliner, Scott D. Patterson, Danielle M. Townsley, Sophie E. Wildsmith, Barbara A. Zehnbauer
npj Precision Oncology · Springer Nature · 2026-11-18 · DOI: 10.1038/s41698-026-01765-8

Abstract

npj Precision Oncology, Published online: 18 November 2026; doi:10.1038/s41698-026-01765-8 Accelerating access to precision oncology trials: risk-benefit framework for local biomarker tests for patient enrollment

Read at publisher →

Similar articles